Epigallocatechin-3-O-gallate alleviates the malignant phenotype in A-431 epidermoid and SK-BR-3 breast cancer cell lines

References

• Appert-Collin A, Hubert P, Cremel G, Bennasroune A. 2015. Role of ErbB receptors in cancer cell migration and invasion. Front Pharmacol. 6:e283.
   PubMed Web of Science ®Google Scholar
• Chen XQ, Hu T, Han Y, Huang W, Yuan HB, Zhang YT, Du Y, Jiang YW. 2016. Preventive effects of catechins on cardiovascular disease. Molecules. 21:e1759.
   PubMed Web of Science ®Google Scholar
• Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y. 2001. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev. 10:53–58.
   PubMed Web of Science ®Google Scholar
• Dheeraj A, Rigby CM, O'bryant CL, Agarwal C, Singh RP, Deep G, Agarwal R. 2017. Silibinin treatment inhibits the growth of Hedgehog inhibitor-resistant basal cell carcinoma cells via targeting EGFR-MAPK-Akt and Hedgehog signaling . Photochem Photobiol. 93:999–1007.
   PubMed Web of Science ®Google Scholar
• Dhillon AS, Hagan S, Rath O, Kolch W. 2007. MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
   PubMed Web of Science ®Google Scholar
• Elizalde PV, Cordo Russo RI, Chervo MF, Schillaci R. 2016. ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy. Endocr Relat Cancer. 23:243–257.
   PubMed Web of Science ®Google Scholar
• Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nat Protoc. 1:2315–2319.
   PubMed Web of Science ®Google Scholar
• Grandis JR, Tweardy DJ. 1993. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 53:3579–3584.
   PubMed Web of Science ®Google Scholar
• Hsuuw YD, Chan WH. 2007. Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells. Ann N Y Acad Sci. 1095:428–440.
   PubMed Web of Science ®Google Scholar
• Hynes NE, Lane HA. 2005. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 5:341–354.
   PubMed Web of Science ®Google Scholar
• Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH. 2017. Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells. Onco Targets Ther. 10:137–144.
   PubMed Web of Science ®Google Scholar
• Lambert JD, Hong J, Kim DH, Mishin VM, Yang CS. 2004. Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. J Nutr. 134:1948–1952.
   PubMed Web of Science ®Google Scholar
• Lee JH, Jeong YJ, Lee SW, Kim D, Oh SJ, Lim HS, Oh HK, Kim SH, Kim WJ, Jung JY. 2010. EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G. Cancer Lett. 290:68–75.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, Lambert G, Mohr S, Yang CS. 2002. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev. 11:1025–1032.
   PubMed Web of Science ®Google Scholar
• Liang CC, Park AY, Guan JL. 2007. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2:329–333.
   PubMed Web of Science ®Google Scholar
• Masuda M, Suzui M, Lim JT, Weinstein IB. 2003. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res. 9:3486–3491.
   PubMed Web of Science ®Google Scholar
• Mocanu MM, Ganea C, Georgescu L, Varadi T, Shrestha D, Baran I, Katona E, Nagy P, Szöllősi J. 2014. Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells. J Nat Prod. 77:250–257.
   PubMed Web of Science ®Google Scholar
• Molino S, Dossena M, Buonocore D, Ferrari F, Venturini L, Ricevuti G, Verri M. 2016. Polyphenols in dementia: from molecular basis to clinical trials. Life Sci. 161:69–77.
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Okuda S, Miyazawa T. 1997. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem. 61:1981–1985.
   PubMed Web of Science ®Google Scholar
• Nicholson KM, Anderson NG. 2002. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 14:381–395.
   PubMed Web of Science ®Google Scholar
• Nowakowska A, Tarasiuk J. 2016. Comparative effects of selected plant polyphenols, gallic acid and epigallocatechin gallate, on matrix metalloproteinases activity in multidrug resistant MCF7/DOX breast cancer cells. Acta Biochim Pol. 63:571–575.
   PubMed Web of Science ®Google Scholar
• Ohishi T, Goto S, Monira P, Isemura M, Nakamura Y. 2016. Anti-inflammatory action of green tea. Antiinflamm Antiallergy Agents Med Chem. 15:74–90.
   PubMedGoogle Scholar
• Oliveira MR, Nabavi SF, Daglia M, Rastrelli L, Nabavi SM. 2016. Epigallocatechin gallate and mitochondria-A story of life and death. Pharmacol Res. 104:70–85.
   PubMed Web of Science ®Google Scholar
• Petras M, Lajtos T, Friedlander E, Klekner A, Pintye E, Feuerstein BG, Szollosi J, Vereb G. 2013. Molecular interactions of ErbB1 (EGFR) and integrin-β1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance. Neuro-oncology. 15:1027–1040.
   PubMed Web of Science ®Google Scholar
• Pianetti S, Guo S, Kavanagh KT, Sonenshein GE. 2002. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res. 62:652–655.
   PubMed Web of Science ®Google Scholar
• Prokhorova EA, Zamaraev AV, Kopeina GS, Zhivotovsky B, Lavrik IN. 2015. Role of the nucleus in apoptosis: signaling and execution. Cell Mol Life Sci. 72:4593–4612.
   PubMed Web of Science ®Google Scholar
• Rana A, Sharma E, Rawat K, Sharma R, Verma S, Padwad Y, Gulati A. 2016. Screening and purification of catechins from underutilized tea plant parts and their bioactivity studies. J Food Sci Technol. 53:4023–4032.
   PubMed Web of Science ®Google Scholar
• Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, Hortobagyi GN. 2009. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist. 14:320–368.
   PubMed Web of Science ®Google Scholar
• Sakamuru S, Li X, Attene-Ramos MS, Huang R, Lu J, Shou L, Shen M, Tice RR, Austin CP, Xia M. 2012. Application of a homogenous membrane potential assay to assess mitochondrial function. Physiol Genomics. 44:495–503.
   PubMed Web of Science ®Google Scholar
• Scaltriti M, Baselga J. 2006. The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res. 12:5268–5272.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Deguchi A, Joe AK, McKoy JF, Moriwaki H, Weinstein IB. 2005. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exp Ther Oncol. 5:69–78.
   PubMedGoogle Scholar
• Singh T, Katiyar SK. 2011. Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition. PLoS One. 6:e25224.
   PubMed Web of Science ®Google Scholar
• Stearns ME, Amatangelo MD, Varma D, Sell C, Goodyear SM. 2010. Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice. Am J Pathol. 177:3169–3179.
   PubMed Web of Science ®Google Scholar
• Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H. 1998. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis. 19:1771–1776.
   PubMed Web of Science ®Google Scholar
• Sulzmaier FJ, Jean C, Schlaepfer DD. 2014. FAK in cancer: mechanistic findings and clinical applications. Nat Rev Cancer. 14:598–610.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Dobashi Y, Sakurai H, Nishikawa K, Hanawa M, Ooi A. 2005. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study. Cancer. 103:1265–1273.
   PubMed Web of Science ®Google Scholar
• Tan M, Yu D. 2007. Molecular mechanisms of erbB2-mediated breast cancer chemoresistance. Adv Exp Med Biol. 608:119–129.
   PubMed Web of Science ®Google Scholar
• Tao L, Forester SC, Lambert JD. 2014. The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells. Mol Nutr Food Res. 58:665–676.
   PubMed Web of Science ®Google Scholar
• Tazzari PL, Cappellini A, Grafone T, Mantovani I, Ricci F, Billi AM, Ottaviani E, Conte R, Martinelli G, Martelli AM. 2004. Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry. Br J Haematol. 126:675–681.
   PubMed Web of Science ®Google Scholar
• Tian R, Li Y, Gao M. 2015. Shikonin causes cell-cycle arrest and induces apoptosis by regulating the EGFR-NF-kappaB signalling pathway in human epidermoid carcinoma A431 cells. Biosci Rep. 35:e00189.
   PubMed Web of Science ®Google Scholar
• Vedula SR, Ravasio A, Lim CT, Ladoux B. 2013. Collective cell migration: a mechanistic perspective. Physiology (Bethesda). 28:370–379.
   PubMed Web of Science ®Google Scholar
• Wieduwilt MJ, Moasser MM. 2008. The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci. 65:1566–1584.
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang H. 2011. Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res. 55:819–831.
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang H. 2016. Cancer preventive activities of tea catechins. Molecules. 21:e1679.
   PubMed Web of Science ®Google Scholar
• Yarden Y, Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2:127–137.
   PubMed Web of Science ®Google Scholar